Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1
- Type
- Expression of concern
- Notice date
- 5/29/2020 0:00
- Journal
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Publisher
- Springer
- Notice DOI
- 10.1007/s00210-019-01687-2
- Original paper DOI
- 10.1007/s00210-019-01687-2